For more than 50 years, we’ve championed a trade relationship that’s transparent, dynamic, and fair.
The US-China Business Council (USCBC) appreciates the opportunity to submit comments on behalf of its member companies to the Standing Committee of the National People’s Congress (NPCSC) on the Draft Revision to the Trademark Law (herein, “the Draft”).
The US-China Business Council (USCBC) appreciates the opportunity to submit comments on behalf of its member companies to the Standing Committee of the National People’s Congress (NPCSC) on the Draft Revision to the Trademark Law (herein, “the Draft”).
The US-China Business Council (USCBC) appreciates the opportunity to submit comments on behalf of its member companies to the State Administration for Market Regulation (SAMR) on the draft Regulations on E-Commerce Platforms’ Assistance in the Investigation and Handling of Trademark Infringement Cases (herein after referred to as “the Draft”).
The US-China Business Council (USCBC) welcomes the opportunity to submit comments to the Office of the United States Trade Representative (USTR) regarding the initiation of the Section 301 investigation into China’s implementation of the Economic and Trade Agreement Between the Government of the United States of America and the Government of the People’s Republic of China (“Phase One Agreement”).
The US-China Business Council (USCBC) welcomes the opportunity to submit comments to the Department of Commerce regarding the Expansion of End-User Controls to Cover Affiliates of Certain Listed Entities interim final rule (henceforth the “Affiliates Rule”).
USCBC welcomes the opportunity to submit comments to the Bureau of Industry and Security (BIS) on the Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices.
The US-China Business Council (USCBC) appreciates the opportunity to submit comments on behalf of its member companies to the National Medical Products Administration (NMPA) regarding the draft Implementation Regulations on Pharmaceutical Test Data Protection (Trial) (hereinafter referred to as “the Regulations”) and the draft Working Procedures on Pharmaceutical Test Data Protection (hereinafter referred to as “the Procedures”).
The US-China Business Council (USCBC) welcomes the opportunity to submit comments to the Bureau of Industry and Security (BIS) on the Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients.
The US-China Business Council (USCBC) welcomes the opportunity to provide feedback to the Department of the Treasury (Treasury) regarding the Outbound Investment Security Program (OISP) established under the executive order of August 9, 2023, “Addressing United States Investment in Certain National Security Technologies and Products in Countries of Concern” (outbound order).
The US-China Business Council (USCBC) welcomes the opportunity to submit comments to the Office of the US Trade Representative’s (USTR) Notice of Proposed Action Pursuant to the Section 301 Investigation of China’s Targeting of the Maritime, Logistics, and Shipbuilding Sectors for Dominance, as described in Docket No. USTR-2025-0002. We appreciate USTR’s efforts to address concerns about China’s dominance in the shipbuilding sector and its implications for US economic and national security interests.
